• FDA clears first dual-lead nerve stimulator for pain relief fiercebiotech
    August 21, 2018
    The FDA granted clearance to SPR Therapeutics’ single- and dual-lead peripheral nerve stimulation devices as minimally invasive, non-opioid alternatives, implanted for up to 60 days for relieving acute and chronic pain, including postoperative and post-tr
PharmaSources Customer Service